Metropolis Healthcare Share Price Today | Stock Price & Metropolis Healthcare Share Screener

Track the current stock price of Metropolis Healthcare with an interactive chart. Analyse METROPOLIS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Metropolis Healthcare stock quote in one place.

The quote of ₹553.60 sits between the 52-week low of ₹421.75 and the 52-week high of ₹2,050.50, and the latest session moved 2.92% from the previous close.

Screen Metropolis Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for METROPOLIS shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare Services sector and the Healthcare Service Provider industry, with Ameera Sushil Shah listed as chairperson or CEO, and it trades under ISIN INE112L01020.

Metropolis Healthcare Limited is an Indian diagnostic services company operating across India and Africa. Founded in 1980 as a pathology partnership, it has evolved into a public company offering a wide range of clinical laboratory tests and profiles. The company operates through a hub and spoke model with 115 clinical...more

Classification

Identifiers and Leadership

Screen METROPOLIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹2,138, up from ₹1,867 in 2025.

Latest statistics put total assets at ₹2,138 and shareholder funds at ₹1,525, with a leverage ratio of 0.15.

Screen Metropolis Healthcare income statement and profit fundamentals. Analyze METROPOLIS quarterly results. Metropolis Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹433 and net profit was ₹51, equal to earnings per unit of ₹2.46, at an operating margin of 25%.

In that period expenses were ₹317, interest cost ₹8 and tax ₹19. The next period listed, 2026-Jun, shows revenue of ₹455 and net profit of ₹57.

Screen METROPOLIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹351, and net cash flow was an inflow of ₹15.

Over the same period, investing activities used ₹220 and financing activities used ₹115.

See Metropolis Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Metropolis Healthcare promoter holding and ownership changes for METROPOLIS on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 48.87%, foreign institutions 10.43%, domestic institutions 35.79% and the public 3.99%, spread across 48,488 shareholders.

The shareholder count was 48,488 in 2026-Mar, compared with 50,636 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Metropolis Healthcare. Metropolis Healthcare dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹5.00 per unit for 2026-March, a yield of 0.87%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹5.00, ₹0.00 and ₹4.00 per unit.

See which indices include Metropolis Healthcare stock. Check METROPOLIS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 16 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.

Get Metropolis Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Metropolis Healthcare stock events that may affect METROPOLIS share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated August 18, 2026, with a record date of August 18, 2026.

It is followed by Quarterly Result Announcement dated August 4, 2026 and Dividend dated May 19, 2026.

Screen METROPOLIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen METROPOLIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 5, 2026.

The next most recent announcements are dated September 9, 2026 and September 7, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 9 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.